+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Psychiatry Partnering 2014-2019: Deal trends, players and financials

  • ID: 2485422
  • Report
  • Region: Global
  • 400 pages
  • CurrentPartnering
1 of 5
the Global Psychiatry Partnering 2014-2019: Deal Trends, Players and Financials Report Provides Comprehensive Understanding and Unprecedented Access to the Psychiatry Partnering Deals and Agreements Entered Into by the World's Leading Healthcare Companies

FEATURED COMPANIES

  • 23andMe
  • Breakthrough Diagnostics
  • Enigma Biomedical
  • Life Science Research
  • Optos
  • Somnology
  • MORE
Global Psychiatry Partnering 2014 to 2019 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014.
  • Trends in Psychiatry partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Psychiatry partnering agreement structure
  • Psychiatry partnering contract documents
  • Top Psychiatry deals by value
  • Most active Psychiatry dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Psychiatry disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Psychiatry deals.

The report presents financial deal terms values for Psychiatry deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Psychiatry dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Psychiatry dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Psychiatry deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Psychiatry dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Psychiatry deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Psychiatry partnering deals by specific Psychiatry target announced since 2014. The chapter is organized by specific Psychiatry therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Psychiatry partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Psychiatry partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Psychiatry technologies and products.

Report Scope

Global Psychiatry Partnering 2014 to 2019 is intended to provide the reader with an in-depth understanding and access to Psychiatry trends and structure of deals entered into by leading companies worldwide.

Global Psychiatry Partnering 2014 to 2019 includes:
  • Trends in Psychiatry dealmaking in the biopharma industry since 2014
  • Analysis of Psychiatry deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Psychiatry deal contract documents
  • Comprehensive access to over 500 Psychiatry deal records
  • The leading Psychiatry deals by value since 2014
  • Most active Psychiatry dealmakers since 2014
The report includes deals for the following indications: Akathisia, Anxiety disorder, Generalised anxiety disorder, Panic disorder, Post traumatic stress disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Chronic fatigue syndrome, Cognitive impairment, Delirium, Dementia, Alzheimers, Dementia with lewy bodies, Vascular dementia, Depression, Dystonia, Eating disorder, Anorexia, Bulimia, Learning disability, Aspergers, Autism, Mania, Obsessive compulsive disorder, Personality disorder, Schizophrenia, Sleep disorders, Insomnia, Narcolepsy, Sleep apnoea, Tardive dyskinesia, Tourettes, plus other psychiatric indications.

In Global Psychiatry Partnering 2014 to 2019, available deals and contracts are listed by:
  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Psychiatry Partnering 2014-2019 report provides comprehensive access to available deals and contract documents for over 600 psychiatry deals. Analyzing actual contract agreements allows assessment of the following:
  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?
Global Psychiatry Partnering 2014 to 2019 provides the reader with the following key benefits:
  • In-depth understanding of Psychiatry deal trends since 2014
  • Access Psychiatry deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Psychiatry partner companies
  • Comprehensive access to over 500 links to actual Psychiatry deals entered into by the world’s biopharma companies
  • Indepth review of Psychiatry deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Psychiatry opportunities
  • Uncover companies actively partnering Psychiatry opportunities
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 23andMe
  • Breakthrough Diagnostics
  • Enigma Biomedical
  • Life Science Research
  • Optos
  • Somnology
  • MORE
Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Psychiatry dealmaking
2.1. Introduction
2.2. Psychiatry partnering over the years
2.3. Psychiatry partnering by deal type
2.4. Psychiatry partnering by industry sector
2.5. Psychiatry partnering by stage of development
2.6. Psychiatry partnering by technology type
2.7. Psychiatry partnering by therapeutic indication

Chapter 3 –Financial deal terms for Psychiatry partnering
3.1. Introduction
3.2. Disclosed financials terms for Psychiatry partnering
3.3. Psychiatry partnering headline values
3.4. Psychiatry deal upfront payments
3.5. Psychiatry deal milestone payments
3.6. Psychiatry royalty rates

Chapter 4 – Leading Psychiatry deals and dealmakers
4.1. Introduction
4.2. Most active in Psychiatry partnering
4.3. List of most active dealmakers in Psychiatry
4.4. Top Psychiatry deals by value

Chapter 5 – Psychiatry contract document directory

5.1. Introduction
5.2. Psychiatry partnering deals where contract document available

Chapter 6 – Psychiatry dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Psychiatry therapeutic target

Appendices

Appendix 1 – Directory of Psychiatry deals by company A-Z 2014 to 2019
Appendix 2 – Directory of Psychiatry deals by deal type 2014 to 2019
Appendix 3 – Directory of Psychiatry deals by stage of development 2014 to 2019
Appendix 4 – Directory of Psychiatry deals by technology type 2014 to 2019
Further reading on dealmaking
Deal type definitions

Table of Figures

Figure 1: Psychiatry partnering since 2014
Figure 2: Psychiatry partnering by deal type since 2014
Figure 3: Psychiatry partnering by industry sector since 2014
Figure 4: Psychiatry partnering by stage of development since 2014
Figure 5: Psychiatry partnering by technology type since 2014
Figure 6: Psychiatry partnering by indication since 2014
Figure 7: Psychiatry deals with a headline value
Figure 8: Psychiatry deals with upfront payment values
Figure 9: Psychiatry deals with milestone payment
Figure 10: Psychiatry deals with royalty rates
Figure 11: Active Psychiatry dealmaking activity– 2014 to 2019
Figure 12: Top Psychiatry deals by value since 2014
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 3B Medical
  • 3PrimeDx
  • 23andMe
  • Abbvie
  • AbCellera
  • Academic Drug Discovery Consortium
  • Accera Pharmaceuticals
  • Acer Therapeutics
  • AC Immune
  • Actavis (name changed to Allergan)
  • Actelion
  • AcuraStem
  • AdAlta
  • Adamas Pharmaceuticals
  • Adare Pharmaceuticals
  • Addex Therapeutics
  • Adimab
  • Admera Health
  • Advanced Cooling Therapy
  • Advocate Health Care
  • ADx Healthcare
  • Aelan Cell Technologies
  • Aequus Pharmaceuticals
  • Aerial BioPharma
  • Affymetrix
  • Agena Bioscience
  • AgeneBio
  • Agilis Biotherapeutics
  • Aiforia Technologies
  • Air Force General Hospital
  • AIT Laboratories
  • Akili Interactive Labs
  • Alector
  • Alexion Pharmaceuticals
  • Alexza Pharmaceuticals
  • Alkahest
  • Alkermes
  • Allen Institute for Brain Science
  • Allergan
  • Alphaeon
  • ALS Association
  • Alzamend Neuro
  • Alzeca Biosciences
  • Alzecure Foundation
  • Alzheimer's Association
  • Alzheimer's Drug Discovery Foundation
  • Alzheimer's Foundation of America
  • Alzheimer's Research UK
  • Alzheimer Society Research
  • Alzheimers Research UK
  • AlzProtect
  • Alzyn
  • Amarantus BioSciences
  • Ambry Genetics
  • American Diabetes Association
  • American Heart/Stroke Association
  • American Sleep Apnea Association
  • American Well
  • Amgen
  • Amherst Pharmaceuticals
  • Amneal Pharmaceuticals
  • Amorsa Therapeutics
  • Amydis Diagnostics
  • Analytical Testing Laboratory
  • Anavex Life Sciences
  • Andor Pharmaceuticals
  • ANI Pharmaceuticals
  • Apnea Sciences
  • Apotex
  • APRINOIA Therapeutics
  • Aptinyx
  • Aquinnah Pharmaceuticals
  • Araclon Biotech
  • ARCH Personalized Medicine Initiative
  • Arena Pharmaceuticals
  • Arizona State University
  • Armor
  • Artelo Biosciences
  • Association for Frontotemporal Degeneration
  • Assurex Health
  • Assuta Medical Centers
  • Astellas Pharma
  • Astex Pharmaceuticals
  • AstraZeneca
  • Aurora Cannabis
  • Australian Imaging
  • Biomarker & Lifestyle Flagship Study of Ageing (AIBL)
  • Autifony Therapeutics
  • Autism Speaks
  • AXIM Biotechnologies
  • AxoSim
  • Axxam
  • Bachmann-Strauss Dystonia & Parkinson Foundation
  • Bain Capital
  • Banner Alzheimer's Institute
  • Banner Health
  • Baylor College
  • BDD Pharma
  • Beijing Double-Crane Pharmaceutical
  • Beijing Leadman Biochemistry
  • Berg
  • Best Choice
  • Bestmed
  • Beurer
  • Biametrics
  • Bicycle Therapeutics
  • Bill and Melinda Gates Foundation
  • BioArctic Neuroscience
  • biOasis Technologies
  • Biocodex
  • Biodextris
  • Biogen
  • Biohaven Pharmaceutical Holding
  • Biomedical Catalyst Fund (UK)
  • BioMed X Innovation Center
  • Bionomics
  • Biopharmaceuticals Australia
  • Bioprojet
  • BioTie Therapies
  • Blackfynn
  • BlackThorn Therapeutics
  • Blake Insomnia Therapeutics
  • Blum Center for Health
  • BMC Medical
  • Boehringer Ingelheim
  • Boston Scientific
  • Boston University
  • Boston University School of Medicine
  • Bracket
  • Brain & Behavior Research Foundation
  • Brain Balance Achievement Centers
  • Brain Biomarker Solutions in Gothenburg
  • Brainsway
  • Breakthrough Diagnostics
  • Breathe ECig
  • Breckenbridge Pharmaceutical
  • Brigham and Women's Hospital
  • BrightFocus Foundation
  • Bristol-Myers Squibb
  • Broad Institute
  • Buck Institute for Age Research
  • BullFrog AI
  • C2N Diagnostics
  • C4 Therapeutics
  • C4X Discovery
  • Cadent
  • Calico
  • Camargo Pharmaceutical Services
  • Cambridge Brain Sciences
  • Cambridge Cognition
  • CannRx Technology
  • Cannvalate
  • Caprion Biosciences
  • Caputron Medical
  • Cardiff University
  • CareCentrix
  • CareFusion
  • Carna BioSciences
  • Case Western Reserve University
  • Casma Therapeutics
  • Catalent Pharma Solutions
  • CavoGene LifeSciences
  • CEITEC
  • Celgene
  • Cellectricon
  • Cellular Dynamics International
  • Centene
  • Center for iPS Cells Research and Application
  • Cerebain
  • Cerebral Therapeutics
  • Cerecor
  • Cerevel Therapeutics
  • Certainty Health
  • Cerveau Technologies
  • Cervel Neurotech
  • Chaperone Technologies
  • ChemDiv
  • Children's Hospital Boston
  • Children's Minnesota
  • Chronos Therapeutics
  • Chugai Pharma Marketing
  • Cingulate Therapeutics (CTx)
  • Circuit Therapeutics
  • City of Hope
  • Cleveland Clinic
  • Click Therapeutics
  • Clinical Imaging Research Centre
  • Cloud Pharmaceuticals
  • CluePoints
  • Cogito
  • Cognetivity Neurosciences
  • Cognition Kit
  • Cognition Therapeutics
  • Cognoa
  • CogState
  • Cohen Veterans Bioscience
  • Columbia University
  • Complement Pharma
  • Compumedics
  • Confo Therapeutics
  • Connecticut Children’s Medical Center
  • Context Therapeutics
  • Coriell Institute for Medical Research
  • Corium International
  • Cortex Pharmaceuticals
  • Cortexyme
  • Cortice Biosciences
  • Corvida Medical
  • COTA
  • Courtagen Life Sciences
  • CRC Health
  • CRISPR Therapeutics
  • Crossbeta Biosciences
  • CryoPort
  • Cure Alzheimer’s Fund
  • CURE Pharmaceutical
  • Cypralis
  • Cyrenaic Pharmaceuticals
  • Cytox
  • Dacadoo
  • Daiichi Sankyo
  • Dainippon Sumitomo Pharma
  • Dalhousie University
  • Defense Advanced Research Projects Agency
  • Dehaier Medical Systems
  • Delivering Scientific Innovation for Autism (DELSIA)
  • Dementia Consortium
  • Dementia Discovery Fund
  • Denali Therapeutics
  • Dengg Medizintechnik
  • Denovo Biopharma
  • Department of Health and Human Services
  • Department of Veterans Affairs
  • DiamiR
  • Dicerna Pharmaceuticals
  • Drukier Institute for Children's Health
  • DSG
  • DuChemBio
  • Duke University
  • Duke University Medical Center
  • Durect
  • DyNAbind
  • Dystonia Europe
  • Dystonia Medical Research Foundation
  • DZNE German Center for Neurodegenerative Diseases
  • E3x Bio
  • EarlySense
  • Early Signal Foundation
  • Ecole Polytechnique Federale de Lausanne
  • Edith Cowan University (ECU)
  • eemagine
  • Egenix
  • Ehave
  • Eisai
  • Eli Lilly
  • Elite Pharmaceuticals
  • Ellison Medical Foundation
  • Emerge Health
  • Emory University
  • Endo International
  • Endotronix
  • Enigma Biomedical
  • Ergomed
  • ERP Biomarker Qualification Consortium
  • Essex Bio-Technology
  • European Parkinson's Disease Association
  • European Prevention of Alzheimer’s dementia Initiative (EPAD)
  • Evecxia
  • Evidation Health
  • Evolent Health
  • Evotec
  • Exeltis
  • Expesicor
  • Exploragen
  • ExScientia
  • Ez Sleep Technologies
  • Fabre Kramer Pharmaceuticals
  • Feinstein Institute for Medical Research
  • Field
  • Florey Institute of Neuroscience and Mental Heath
  • Florida Atlantic University Research
  • Flowonix
  • Fondazione Telethon
  • Food and Drug Administration (FDA)
  • Forest Pharmaceuticals
  • FORMA Therapeutics
  • Foundation for the National Institutes of Health (FNIH)
  • Fudan University
  • Fujirebio Diagnostics
  • FusionHealth
  • Galen
  • GCA Therapeutics
  • Genco Sciences
  • Genentech
  • Genoma
  • Georgetown University
  • Gilead Sciences
  • Ginkgo BioWorks
  • GlaxoSmithKline
  • GliaCure
  • Global Alliance for Innovation in Neuroscience
  • Global Alzheimer's Platform (GAP)
  • Gnome Diagnostics
  • Gnosis Bioresearch
  • Golden Meditech
  • Gour Medical
  • Grifols
  • Grupo Ferrer
  • Hackensack Meridian Health
  • Hainan Sinotau Pharmaceutical
  • Hannover Medical School
  • Harmony Biosciences
  • Harvard Medical School
  • Harvard University
  • Health Connexions
  • Healthsense
  • HEI Life Sciences
  • Helius Medical Technologies
  • Helix
  • Helsinki University Central Hospital (HUCH) Comprehensive Cancer Center
  • Helsinn Healthcare
  • HemispheRx Biopharma
  • Heptares Therapeutics
  • Hertie Foundation
  • HLS Therapeutics
  • HMNC Brain Health
  • Holobiome
  • Hong Kong Baptist University
  • Horizon Healthcare Services
  • Human Metabolome Technologies
  • I-mab
  • iBIO Institute’s PROPEL Center
  • IBM
  • Icagen
  • Icahn School of Medicine at Mount Sinai
  • ICAN
  • Icon
  • Ildong Pharmaceutical
  • ILiAD Biotechnologies
  • Imanova
  • ImmunoBrain Checkpoint
  • Impax Laboratories
  • Impel NeuroPharma
  • Imperial College London
  • India Globalization Capital
  • Indivior
  • Inexia
  • Innovate UK
  • Innovative Medicines Initiative (IMI)
  • Inoviem Scientific
  • Inovio Pharmaceuticals
  • Institute for Functional Medicine
  • IntegraGen
  • IntelliCell BioSciences
  • Intellipharmaceutics
  • InteRNA Technologies
  • inVentiv Health
  • inviCRO
  • Ionis Pharmaceuticals
  • ISIS Innovation
  • Itamar Medical
  • IXICO
  • Janssen Biotech
  • Janssen Korea
  • Janssen Pharmaceuticals
  • Janssen Pharmaceutica NV
  • Janssen Research & Development
  • Japan Tobacco
  • Jazz Pharmaceuticals
  • Jiangsu NHWA Pharmaceutical
  • John Ballard
  • Johns Hopkins University
  • Johnson & Johnson
  • Johnson & Johnson Consumer Companies
  • Johnson & Johnson Innovation
  • K-PAX Pharmaceuticals
  • Kadimastem
  • Kalgene Pharmaceuticals
  • Kaneh-B
  • Karuna Pharmaceuticals
  • Keio Gijuku University
  • Kelyniam Global
  • KemPharm
  • Kings College London
  • KinoPharma
  • Klogene Therapeutics
  • Kogenix
  • Kuhnil Pharmaceuticals
  • Lannett
  • LCS Therapeutics
  • Lead Discovery Center
  • Les Laboratoires Servier
  • Lieber Institute
  • LifeArc
  • Life Science Research
  • Ligand Pharmaceuticals
  • Limbix
  • Liminal VR
  • Linde Gas
  • LineaRx
  • Living Heart Foundation
  • Lonza
  • Lucerne Biosciences
  • Luc Therapeutics
  • Lundbeck
  • Lupin
  • Lupus Foundation of America (LFA)
  • Lutheran Medical Center
  • Luye Pharma Group
  • Lyndra Therapeutics
  • M2i
  • Mallinckrodt Pharmaceuticals
  • Marinus Pharmaceuticals
  • MaRS Innovation
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology
  • Max-Planck
  • Mayo Clinic
  • McGill University
  • McLean Hospital
  • Medibio
  • Medical Research Council
  • Medical Technology Enterprise Consortium
  • MediCann Handels
  • Medicollector
  • MedImmune
  • Mediso
  • Medison Pharma
  • Medtronic
  • Meiji Seika
  • MeiraGTx
  • Merck and Co
  • Merck Serono
  • Merz
  • Metabolon
  • Methodist Hospital Houston
  • Metrion Biosciences
  • MGC Diagnostics
  • MGC Pharma
  • Michael J Fox Foundation
  • Michigan State University
  • MindImmune Therapeutics
  • Mindstrong Health
  • Minerva Neurosciences
  • Mission Pharmacal
  • Mission Therapeutics
  • Mitsubishi Tanabe Pharma
  • Modern Dental Group
  • Molecular Stethoscope
  • Moleculera Labs
  • MorphoSys
  • MPI Cognition
  • Muses Labs
  • MyHealios
  • MYnd Analytics
  • Myriad Genetics
  • myTomorrows
  • MyVytalics
  • Nancy Lurie Marks Family Foundation
  • Nansen Neuroscience Network
  • NantHealth
  • Nanyang Technological University
  • National Health Service
  • National Institute of Mental Health
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging
  • National Institute on Drug Abuse (NIDA)
  • National Institutes for Quantum and Radiological Science and Technology
  • National Institutes of Health
  • National Physical Laboratory
  • National Research Council Canada
  • National Science Foundation
  • National University Hospital
  • National University of Singapore
  • Natural Sciences and  Engineering Research Council of Canada
  • Naurex
  • Navidea Biopharmaceuticals
  • Neomed Institute
  • Neos Therapeutics
  • Nestle Health Science
  • Neurexpert
  • Neurimmune Therapeutics
  • Neurim Pharmaceuticals
  • Neuro Assessment Systems
  • Neurocrine Biosciences
  • NeuroEM Therapeutics
  • Neuromed
  • Neuronetics
  • Neuronetrix
  • NeurOp
  • NeuroRx
  • NeuroSigma
  • Neurosoft
  • NeuroTech
  • Neurotez
  • Neurotrack
  • Neurotrope BioScience
  • NeuroVigil
  • Neurovirtual
  • NeuroVision Imaging
  • Newcastle University
  • New York Genome Center (NYGC)
  • NextCODE Health
  • Nihon Kohden
  • Nippon Chemiphar
  • NOCTEM
  • Northern California Institute for Research and Education
  • Nortis
  • Norwegian Research Council
  • Nostrum Pharmaceuticals
  • NovaDel Pharma
  • Novartis
  • Nova Southeastern University
  • Noven Pharmaceuticals
  • Novoron Bioscience
  • Numerate
  • Nutriband
  • Nuvelution Pharma
  • OKI Electric Industry
  • Oklahoma Center for the Advancement of Science and Technology
  • Oligomerix
  • OnDeckBiotech
  • OnDosis
  • Ono Pharmaceutical
  • OptiNose
  • Optos
  • Oregon Health Sciences University
  • Orexia Therapeutics
  • Orexigen Therapeutics
  • Orion
  • Ortho-Clinical Diagnostics
  • Oryzon
  • Osaka University
  • Osmotica Pharmaceuticals
  • Otsuka
  • Ouraring
  • Oventus
  • Pacific Medical
  • Pain Therapeutics
  • Paladin Labs
  • Parexel
  • Parkinson's UK
  • Patheon
  • Pat Summitt Foundation
  • Paul G Allen Family Foundation
  • Pax Neuroscience
  • PEAR Therapeutics
  • Pennsylvania State University
  • Peptron
  • PerkinElmer
  • Pernix Therapeutics
  • Perrigo
  • Pfizer
  • Pfizer Korea
  • Pharmaceutix
  • Pharmacological research Institute Mario Negri
  • Pharmasum Therapeutics
  • Pherin Pharmaceuticals
  • Philips
  • Philips Healthcare
  • PhoreMost
  • Pioneer Pharma
  • Piramal Imaging
  • Pixvana
  • Polichem
  • PPD
  • Praxis
  • Premier Inc
  • Preora Diagnostics
  • Probiodrug
  • Proclara Biosciences
  • Prometheus Laboratories
  • Protea Biosciences
  • Prothena Biosciences
  • PsyBrain
  • PsychoGenics
  • Purdue Pharma
  • Q BioMed
  • QPS
  • Quadrant Biosciences
  • QuiO Technologies
  • R-Biopharm
  • Recipharm
  • Recombinant Technologies
  • Recombinetics
  • Regenxbio
  • Remarkable Technologies
  • Rentschler Biotechnologie
  • Research Foundation of State University of New York
  • Reset Therapeutics
  • Resilience Therapeutics
  • Resmed
  • Rett Syndrome Research Trust
  • Rhinomed
  • Ridge Diagnostics
  • Rio Grande Neurosciences
  • Roche
  • Roche Diagnostics
  • RogCon Biosciences
  • Roivant Sciences
  • Rosalind Franklin University of Medical Sciences
  • Rosetta Genomics
  • Roskamp Institute
  • Royal Philips Electronics
  • RPRD Diagnostics
  • Rugen Therapeutics
  • Sagent Pharmaceuticals
  • Sage Therapeutics
  • Sajo Consulting
  • Saladax Biomedical
  • Salk Institute
  • SanBio
  • Sandoz
  • Saniona
  • Sanmina
  • Sanofi
  • Savonix
  • Schrodinger
  • Science 37
  • Science Exchange
  • Seelos Therapeutics
  • Sellas Clinicals Holding
  • Senexta
  • Senhwa Biosciences
  • Seqster
  • ShangPharma
  • Sheba Medical Center
  • Shionogi
  • Shionogi Pharma
  • Shire Pharmaceuticals
  • Siemens Healthineers
  • Sintact Medical Systems
  • Sirion Biotech
  • SK Biopharmaceuticals
  • Skyhawk Therapeutics
  • SleepScore Labs
  • SOM Biotech
  • Somnology
  • Sonkei Pharmaceuticals
  • Sonora Quest Laboratories
  • Soterix Medical
  • Sound Pharmaceuticals
  • SpringWorks Therapeutics
  • SRI International
  • Stanford University
  • Stanford University School of Medicine
  • Stellar Biotechnologies
  • Stemedica Cell Technologies
  • Stemina Biomarker Discovery
  • Striiv
  • SunGen
  • Sunovion Pharmaceuticals
  • Sun Pharma Advanced Research Company
  • SUNY Upstate Medical University
  • Supernus Pharmaceuticals
  • SV Life Science
  • SynapDx
  • Syndesi Therapeutics
  • Synlogic
  • T3D Therapeutics
  • Takeda Pharmaceutical
  • Takeda Pharmaceuticals U.S.A
  • Targacept
  • Target ALS Foundation
  • Targeted Medical Pharma
  • Tauriga Sciences
  • Teijin
  • Tetra Discovery Partners
  • TET Systems
  • Teva Pharmaceutical Industries
  • Teva Pharmaceuticals USA
  • TFS International
  • The American Senior Housing Association
  • The New York Stem Cell Foundation
  • Theranexus
  • Therapix Bio
  • The Regents of the University of California
  • Thiel Foundation
  • Tilray
  • to-BBB Technologies
  • Todos Medical
  • Tokyo Metropolitan Institute of Gerontology
  • Torrey Pines Investment
  • Transdermal Delivery Solutions
  • Transition Therapeutics
  • Translational Genomics Research Institute
  • Translational Software
  • Transparency Life Sciences
  • Treventis
  • Tucker Medical
  • UCB
  • UK Biobank
  • UK Dementias Research Platform
  • UK Government
  • uMETHOD Health
  • University College Dublin
  • University College London
  • University Gottingen
  • University of Arizona
  • University of Barcelona
  • University of Birmingham
  • University of Bonn
  • University of Bristol
  • University of British Columbia
  • University of Calgary
  • University of California
  • San Diego
  • University of California Irvine
  • University of California Los Angeles
  • University of California San Francisco
  • University of Cambridge
  • University of Chicago
  • University of Colorado
  • University of Colorado Denver
  • University of Illinois
  • University of Leipzig
  • University of Leuven
  • University of Manchester
  • University of Manitoba
  • University of Michigan
  • University of Minnesota
  • University of North Carolina
  • University of Oxford
  • University of Pennsylvania
  • University of Pittsburgh
  • University of Rochester
  • University of Rome
  • University of Southampton
  • University of South Florida
  • University of Tennessee
  • University of Toronto
  • University of Utah
  • University of Washington
  • University of Wisconsin-Madison
  • Uppsala University
  • US Army Medical Research and Material Command
  • US Army Research Laboratory
  • US Department of Veteran Affairs
  • US Navy
  • US Veterans Administration
  • UW Medicine
  • Valeant Pharmaceuticals
  • VA Medical Center (VAMC)
  • Vanda Pharmaceuticals
  • Vanderbilt University
  • Vantari Genetics
  • Vect-Horus
  • Verily
  • Vernalis
  • Viome
  • VistaGen Therapeutics
  • Vividion Therapeutics
  • Vodafone
  • Voyager Therapeutics
  • VU Medical Center
  • Walter Reed Army Institute of Research
  • Washington University in St Louis
  • WAVE Life Sciences
  • Weill Cornell Medical College
  • Weizmann Institute
  • Wellcome Trust
  • Wellness Open Living Labs
  • Weston Brain Institute
  • WinterLight Labs
  • Worcester Polytechnic Institute (WPI)
  • Wyss Institute
  • X-chem
  • XERIS Pharmaceuticals
  • Xonovo
  • XRGenomics
  • Yale University
  • Yissum Research Development
  • Yom Chai
  • York Instruments
  • Yumanity Therapeutics
  • Zelegent
  • ZhiNuo
  • ZYUS Life Sciences
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll